2013, Number 5
<< Back Next >>
Acta Pediatr Mex 2013; 34 (5)
Use of generic medication for epilepsy: valproic acid
Carmona-Aparicio L, Chávez-Pacheco JL, Alemón R, Rivera-Espinosa L
Language: Spanish
References: 13
Page: 303-305
PDF size: 117.48 Kb.
Text Extraction
No abstract
REFERENCES
Löscher W. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory aminoacids in the brain. Neurochem Res. 1993;18:485-502.
Vriend JP, Alexiuk NA. Effects of valproate on aminoacid and monoamine concentrations in striatum of audiogenic seizure-prone Balb/c mice. Mol Chem Neuropathol. 1996;27:307-24.
Buchhalter JR, Dichter MA. Effects of valproic acid in cultured mammalian neurons. Neurology. 1986;36:259-62.
Farrant M, Webster RA. Neuronal activity, amino acid concentration and amino acid release in the substantia nigra of the rat after sodium valproate. Brain Res. 1989;504: 49-56.
Dreier JP, Heinemann U. Late low magnesium-induced epileptiform activity in rat entorhinal cortex slices becomes insensitive to the anticonvulsant valproic acid. Neurosci Lett. 1990;119:68-70.
Gaillard WD, Zeffiro T, Fazilat S, DeCarli C, Theodore WH. Effect of valproate on cerebral metabolism and blood flow: an 18F-2-deoxyglucose and 150 water positron emission tomography study. Epilepsia. 1996;37:515-21.
Proyecto de Norma Oficial Mexicana PROY-NOM-177- SSA1-1998, que establece las pruebas y procedimientos para demostrar que un medicamento es intercambiable. Requisitos a que deben sujetarse los terceros autorizados que realicen las pruebas. www.salud.gob.mx/unidades/ cofepris/cis/tramites/regmed/pdf/NOM_177.pdf. Consultada 3 de julio del 2012.
Sherwood Brown E, Shellhorn E, Suppes T. Gastrointestinal side-effects after switch generic valproic acid. Pharmacopsychiatry. 1998;31:114.
Berg MJ, Gross RA, Tomaaszewski KJ, Cíngaro WM, Haskins LS. Generics substitution in the treatment of epilepsy: case evidence of breakthrough seizures. Neurology 2008;71(7):525-30.
MacDonald JT. Breakthrough seizure following substitution of Depakene capsules (Abbott) with a generic product. Neurology. 1987;37:1885.
Dhanaraj M, Jayavelu A. Non-equivalence of bioavailability between generic and branded form of sodium valproate. Neurol India. 2004;52(3):398.
Gromov SA, Lipatova LV. The use of generics valparin xr in the treatment of epilepsy. Zh Nevrol Pslkhiatr Im S S Korsakova. 2007;107(10):44-6.
Vadney VJ, Kraushaar KW. Effects of switching from Depakene to generic valproic acid on individuals with mental retardation. Ment Retard. 1997;35:468-72.
Full text